NRX Pharmaceuticals Inc share price logo

NRX Pharmaceuticals Inc Share Price

NASDAQ: NRXP

Small Cap

$2.96

-0.25

(-7.66%)

as on

NRX Pharmaceuticals Inc Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.88
    $3.29
    downward going graph

    2.70%

    Downside

    11.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.62
    $3.84
    downward going graph

    45.27%

    Downside

    29.73%

    Upside

    downward going graph

NRX Pharmaceuticals Inc share price movements today

Previous Close
$3.20
Open
$3.20
Volume
3.4M
Day's Low - High
$2.88 - $3.29
52 Week Low - High
$1.62 - $3.84

NRX Pharmaceuticals Inc Historical Returns

1 Month Return
+ 72.97 %
3 Month Return
+ 41.59 %
1 Year Return
+ 71.12 %
3 Year Return
-46.67 %
5 Year Return
0 %

NRX Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check NRX Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$84.3M

EPS (TTM)

0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-16.1M

Revenue (TTM)

1.2M

Profit Margin

0.00%

Return On Equity TTM

-682.61%

NRX Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NRX Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NRX Pharmaceuticals Inc image
NRX Pharmaceuticals Inc
BUY$84.3MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B126.09%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.7B99.85%28.6532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for NRX Pharmaceuticals Inc Stock including INR - Dollar returns

The NRX Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

NRX Pharmaceuticals Inc investment value today

Current value as on today

₹1,73,759

Returns

₹73,759

(+73.76%)

Returns from NRX Pharmaceuticals Inc Stock

₹58,289 (+58.29%)

Dollar Impact

₹15,470 (+15.47%)

Analyst Recommendation on NRX Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for NRX Pharmaceuticals Inc. Average target price of $38

NRX Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on NRX Pharmaceuticals Inc.

What analysts predicted

92.21%UPSIDE

Target Price

$38

Current Price

$2.96

Analyzed by

9 Analysts

Target

$38.00

NRX Pharmaceuticals Inc target price $38, a slight upside of 92.21% compared to current price of $2.96. According to 9 analysts rating.

NRX Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for NRX Pharmaceuticals Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

NRX Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
0
-
-
0
0
-
0
0
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-5
-4
-5
-7
-3
-3
-3
-3
-4
-4
EBITDA
-6
-4
-6
-7
-1
-9
-5
-17
-5
-4
Interest Expense
0
0
0
0
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
-
-
0
0
Income Before Tax
-6
-4
-6
-7
-1
-9
-5
-17
-5
0
Income Tax Expense
0
-1
0
-
-
-
-
-
-
-
Net Income
-6
-4
-6
-7
-1
-9
-5
-17
-5
0
Net Profit Margin
0.00%
-54150.00%
-81600.00%
0.00%
0.00%
-226950.00%
-137800.00%
0.00%
-2433.88%
36.62%

NRX Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
1
Gross Profit
0
0
0
0
0
0
Operating Income
-22
-95
-44
-27
-19
-16
EBITDA
-51
-93
-39
-30
-24
-16
Interest Expense
0
0
4
0
1
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-51
-93
-39
-30
-25
-28
Income Tax Expense
-39
-21
-4
0
-
-
Net Income
-51
-93
-39
-30
-25
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-2336.49%

NRX Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
-6
-7
-1
-9
-5
-17
-5
0
Operating Cash Flow
-3
-3
-3
-2
-2
-3
-4
-2
-3
Investing Cash Flow
-
0
-
-
-
-
-
-2
0
Financing Cash Flow
-1
0
4
2
1
7
1
9
4
Change in Cash
-4
-3
0
0
0
4
-2
4
0

NRX Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-51
-93
-39
-30
-25
-28
Operating Cash Flow
0
0
-2
-37
-39
-21
-10
-14
Investing Cash Flow
0
40
0
0
0
0
-
-2
Financing Cash Flow
0
-39
3
63
32
6
7
23
Change in Cash
0
0
0
25
-7
-15
-3
6

Global Institutional Holdings in NRX Pharmaceuticals Inc

Funds
Holdings
Chicago Partners Investment Group LLC
0.1%
Jane Street Group LLC
0.23%
Commonwealth Equity Services Inc
1.11%
AdvisorShares Investments, LLC
0.99%
SJBENEN ADVISORY, LLC
0.05%
See all

NRX Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 02 December

    Tue, 07:01 PM

    -

    NRx Pharmaceuticals announces FDA receipt of ANDA for KETAFREE™, a preservative-free IV ketamine formulation.

Insights on NRX Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NRXP stock has moved up by 28.0%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NRXP has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.1% return, outperforming this stock by 69.8%

About NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital; and has as a partnership with neurocare Group AG to create a nationwide network of clinics to offer integrated neuroplastic care for the treatment of Depression, PTSD, and other serious mental health disorders. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
OrganisationNRX Pharmaceuticals Inc
Headquarters1201 Orange Street, Wilmington, DE, United States, 19801
IndustryBiotechnology
CEODr. Jonathan C. Javitt M.D., M.P.H.
E-voting on sharesClick here to vote

Key Management of NRX Pharmaceuticals Inc

Name

Title

Dr. Dennis K. McBride Ph.D.

Chief Strategy Officer & Director

Mr. Glenn Tyson

Chief Commercial Officer

Mr. Michael S. Abrams M.B.A.

CFO & Treasurer

Mr. Joseph M. Casper

Chief Operating Officer

Suzanne Messere

Investor Relations

Dr. Philip T. Lavin Ph.D.

Chief Methodologist

Prof. Joshua C. Brown M.D., Ph.D.

Chief Medical Innovation Officer

Dr. Jonathan C. Javitt M.D., M.P.H.

Co-Founder, Chairman, CEO & Chief Scientist Officer

Dr. Riccardo Panicucci Ph.D.

Chief Manufacturing & Technology Officer

FAQs

What is NRX Pharmaceuticals Inc share price today?

NRX Pharmaceuticals Inc share price today is $2.96 as on at the close of the market. NRX Pharmaceuticals Inc share today touched a day high of $3.29 and a low of $2.88.

What is the 52 week high and 52 week low for NRX Pharmaceuticals Inc share?

NRX Pharmaceuticals Inc share touched a 52 week high of $3.84 on and a 52 week low of $1.62 on . NRX Pharmaceuticals Inc stock price today i.e. is closed at $2.96,which is 22.92% down from its 52 week high and 82.72% up from its 52 week low.

What is NRX Pharmaceuticals Inc's market capitalisation today?

NRX Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in NRX Pharmaceuticals Inc Stock (NRXP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NRX Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NRX Pharmaceuticals Inc Shares that will get you 0.5068 shares as per NRX Pharmaceuticals Inc share price of $2.96 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy NRX Pharmaceuticals Inc Stock (NRXP) from India?

Indian investors can start investing in NRX Pharmaceuticals Inc (NRXP) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in NRX Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on NRX Pharmaceuticals Inc share’s latest price of $2.96 as on April 22, 2026 at 1:29 am IST, you will get 3.3784 shares of NRX Pharmaceuticals Inc. Learn more about fractional shares .